Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAVO.L Share News (AVO)

  • There is currently no data for AVO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET COMMENT: Stocks Pointed Flat With Greece, PMIs in Focus

Wed, 03rd Jun 2015 05:59

LONDON (Alliance News) - UK shares are set to open flat Wednesday, as investors continue to keep a wary eye on the negotiations between Greece and its European creditors, with Purchase Manager's Index readings from Asia, Europe and the US also in focus.

"The new deal is expected to be presented today, but given it appears little different in tone or red lines, it seems unlikely that after all these weeks and months of toing and froing between Athens and Brussels that any agreement will be forthcoming," says Michael Hewson, chief market analyst at CMC Markets UK.

A draft agreement between Greece and its international creditors to unlock much-needed cash in exchange for tough reforms by Athens is close to being completed, officials said Tuesday. The last details of the proposed debt deal are being intensively negotiated, eurozone officials said.

Greece is due to make a repayment of EUR300 million to the International Monetary Fund on Friday. However, whether a deal between Athens and its creditors - its eurozone partners and the IMF - can be hammered by the end of the week remains open.

Meanwhile, Eurogroup Chairman Jeroen Dijsselbloem said Tuesday it is "not even theoretically possible" for Greece's lenders to resume support this week while discussions on its economic reforms are ongoing, Reuters reported.

IG says futures indicate the FTSE 100 to open 1 point lower at 6,927.0. The index closed down 0.4% at 6,928.27 Tuesday, due to the continued uncertainty over the Greek debt negotiation, despite a strong performance from the mining sector.

Wall Street also ended lower Tuesday. The DJIA closed down 0.2%, while the S&P 500 and the Nasdaq Composite both ended down 0.1%.

In Asia on Wednesday, the Japanese Nikkei 225 trades down 0.5%, while the Hang Seng trades up 0.8%. The Shanghai Composite is trading down 0.9%.

The FTSE Committee will announce Wednesday its index review decision based Tuesday's closing prices. Aerospace and defence company Meggitt is likely to drop out of the FTSE 100 after a volatile March and a weak share performance in April and May, while satellite communications service provider Inmarsat is set to return to the blue-chip index following a strong run in its shares since the previous index review.

Often, the likely moves become apparent in the days ahead of the index review. However, this time the changes to the FTSE 100, outside of Inmarsat and Meggitt, are too close to call. Wm Morrison Supermarkets, Sports Direct International and Aggreko are amongst the other potential candidates for demotion from the FTSE 100.

In the corporate calendar Wednesday, International Consolidated Airlines Group releases its May traffic statistics, while Dixons Carphone issues a fourth-quarter trading statement. WH Smith also provides a trading statement, and Workspace Group, Quindell, Advanced Oncotherapy, Caffyns and Shires Income publish full-year results. Alternative Networks and EasyHotel release half-year results.

In the economic calendar, Markit Services PMI readings from Italy is due at 0845 BST, as the likes of Germany, the eurozone and the UK are due at 0855 BST and 0900 BST and 0930 BST, respectively. Eurozone's retail sales are due at 1000 BST, while the European Central Bank decision is expected at 1245 BST. In the US, Markit Services and Composite PMI is due at 1445 BST, while EIA crude oil stocks is due at 1530 BST.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
3 May 2024 21:30

IN BRIEF: Advanced Oncotherapy financing talks continue, funds delayed

Advanced Oncotherapy PLC - London-based provider of proton therapy for cancer treatment - Provides update in relation to financing discussions and financial position. Says talks on the proposed financing have continued to make good progress. However, notes there have been further delays and the initial tranche of funding, which is still expected to be around USD15 million, has not yet been received. Hopes this will be received by the end of May but stresses there is no guarantee. Continues to expect the financing to require a restructuring of financial liabilities with a view to providing a long-term financing solution for the company to continue as a going concern. Warns that without additional funding the company is unlikely to be able to continue to trade and would very likely become insolvent and be placed into administration.

Read more
2 Apr 2024 17:35

TRADING UPDATES: Sareum ups retail offer; SThree nabs former ITV exec

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
29 Feb 2024 18:52

EARNINGS AND TRADING: Frontier IP sells last of Exscientia holding

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
2 Feb 2024 14:06

IN BRIEF: Advanced Oncotherapy eyes USD15 million tranche in February

Advanced Oncotherapy PLC - London-based provider of proton therapy for cancer treatment - Regarding its recapitalisation plan, company works alongside investor towards initial tranche of funding, which it expects to be about USD15 million to be received this month. However, it adds that there can be no guarantee that this funding will be received, nor that it will be received on time. Further, Advanced Oncotherapy says it remains in advanced talks with a third-party investor regarding a short-term loan facility which would provide the company with additional short term bridge financing.

Read more
9 Jan 2024 14:06

IN BRIEF: Advanced Oncotherapy in advanced talks regarding loan

Advanced Oncotherapy PLC - London-based provider of proton therapy for cancer treatment - Continues to work on its recapitalisation plan with an unnamed third party investor. Says discussions are at an advanced stage but has not entered into any binding agreements with the investor, nor received any funds. This comes after it signed a non-binding term sheet with the investor in October. The investor is expected to provide funding of up to USD80 million to meet the company's cashflow requirements through to the European certification of the LIGHT System. Notes the treatment of first patients with LIGHT is now targeted for 2024 with certification of the LIGHT System to follow thereafter. Anticipates the financing to be a mixture of equity and debt financing. The firm currently owes GBP28 million to trade and other unsecured creditors and GBP41 million of financial debt.

Read more
23 Oct 2023 18:51

IN BRIEF: Advanced Oncotherapy in talks over possible cash injection

Advanced Oncotherapy PLC - London-based provider of proton therapy for cancer treatment - Updates on financing discussions and current financial position. Signs non-binding term sheet with a third-party investor. Investor is expected to provide funding of up to USD80 million to meet the company's cashflow requirements through to the European certification of the LIGHT System. Notes the treatment of first patients with LIGHT is now targeted for 2024 with certification of the LIGHT System to follow thereafter. Anticipates the financing to be a mixture of equity and debt financing.

Read more
3 Oct 2023 18:29

IN BRIEF: Advanced Oncotherapy results delayed, funding talks continue

Advanced Oncotherapy PLC - London-based provider of proton therapy for cancer treatment - On Friday, says it is not in a position to publish its accounts for the year ended December 31, 2022, and the unaudited interim results for the six months ended June 30, together with the 2022 annual report. Explains the 2023 interim results are contingent on the finalisation and publication of the 2022 annual report.

Read more
17 Jul 2023 21:41

Advanced Oncotherapy plans to raise up to GBP110 million

(Alliance News) - Advanced Oncotherapy PLC on Monday announced a prospective recapitalisation and funding plan to raise up to GBP110 million.

Read more
30 Jun 2023 19:54

TRADING UPDATES: Jadestone Energy holds production and capex targets

(Alliance News) - The following is a round-up of updates by London-listed companies, issued Friday and not separately reported by Alliance News:

Read more
2 Jun 2023 19:37

IN BRIEF: Advanced Oncotherapy optimistic of securing further funding

Advanced Oncotherapy PLC - London-based particle therapy for cancer treatment company - Announces it has received a conversion notice for a portion of the convertible notes, which were issued to a French counterparty, as announced March 1 into new shares in the company. Says 10 convertible notes have been converted worth GBP50,000 at a conversion price of GBP0.25. Company also pays GBP56,702 conversion fee as the conversion price is below the nominal value of the shares. States this will be settled through the issuance of 756,020 new shares. Further, says in talks to raise further funding under the secured loan note agreement as well as through other non-dilutive financing options and is hopeful of securing additional financing during June 2023. Optimistic of a satisfactory outcome on the financing options being explored. In addition, company says it has issued convertible notes totalling GBP34,600 under its secured convertible loan note agreement.

Read more
15 May 2023 21:10

TRADING UPDATES: Online Blockchain keeping ADVFN at "arms length"

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
18 Apr 2023 10:38

Advanced Oncotherapy considers US sale of business to secure funding

(Alliance News) - Advanced Oncotherapy PLC on Tuesday said it is continuing to consider funding options to allow it to complete its first Light machine and begin treating patients later this year.

Read more
20 Mar 2023 13:06

IN BRIEF: Advanced Oncotherapy receives GBP1.2 million in funds

Advanced Oncotherapy PLC - London-based particle therapy for cancer treatment - Receives balance of funds, about GBP1.2 million, due under the secured convertible loan agreements entered into by the company with investors and directors. The balance of funds that have been received by the company includes GBP500,000 that was due to be received from Executive Chair Michael Sinclair by mid-March 2023. Currently, GBP5.0 million has been received from investors under the secured convertible loan note. Says it is also taking steps to raise additional financing.

Read more
1 Mar 2023 21:15

TRADING UPDATES: Galantas to raise GBP1.2 million in private placement

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
18 Jan 2023 21:58

TRADING UPDATES: Bankers net assets drop; Invinity Energy wins funds

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.